Step-by-Step Guide to Administering a Retatrutide Injection In clinical trial settings, retatrutide is given as a subcutaneous injection into the abdomen or outer thigh, using standard technique: clean the site, pinch the skin, insert the needle at 4590 degrees, and dispose of the needle in a sharps bin immediately after use
Regulatory Status Retatrutide has not received approval from Health Canada for any medical indication
This step is also called a flow check or safety test
Another contraindication is the use of GLP-1RA in patients with a history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2 (MEN2 (33, 34, 36)
This content is for informational purposes only and does not constitute medical advice
No controlled studies have demonstrated noticeable weight loss from patch-based products